LENSAR, Inc. (LNSR) Research
LENSAR, Inc. is an established medical device company that specializes in the development and commercialization of an advanced femtosecond laser system. This innovative technology is designed for the surgical treatment of cataracts and the precise management of corneal astigmatism, regardless of whether it's pre-existing or a consequence of surgery. The core of their offering, the LENSAR Laser System, incorporates a suite of exclusive technologies. These are specifically engineered to empower surgeons, enhancing surgical precision, optimizing patient visual results, and ensuring both operational efficiency and consistent procedural outcomes. This is achieved through its sophisticated capabilities in imaging, comprehensive procedure planning, adaptable design features, and unparalleled accuracy. Established in 2004, LENSAR, Inc. is headquartered in Orlando, Florida.
Market snapshot
- Symbol
- LNSR
- Price
- $5.74
- Day change
- -8.31%
- Market cap
- $69.5M
- P/E ratio
- 2.37x
- 52-week range
- 5.06-13.47
- Sector
- Healthcare
- Industry
- Medical - Devices
- Next earnings
- in 2 months
- Analyst price target
- $10.00
Peer companies
Recent insider activity
- HAMMER TODD B — A-Award (17421 shares) on 2026-06-03
- ELLIS THOMAS B — A-Award (17421 shares) on 2026-06-03
- Wong Kendra — A-Award (13066 shares) on 2026-06-03
- Connaughton Alan B. — A-Award (34843 shares) on 2026-06-03
- CURTIS NICHOLAS T — A-Award (130662 shares) on 2026-06-03
Open LENSAR, Inc. (LNSR) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.